Dun & Bradstreet: Bazan overtakes Teva

By SHARON WROBEL
May 9, 2006 06:43

Oil refiner's revenues top pharmaceutical giant; Iscar takes 11th place.

1 minute read.



teva logo 88

teva logo 88. (photo credit: )

The surge in energy prices made Bazan Oil Refineries the largest industrial company in terms of sales volume in 2005, taking the top spot away from Teva Pharmaceutical Industries Ltd., according to the Dun's 100 report of Israel's largest enterprises compiled by Dun & Bradstreet Israel. The global rise in oil and petrol prices helped boost Bazan's revenues by 44 percent to $5.9 billion last year, while Teva dropped to second place as its 9.4% sales growth left it with revenue of $5.25b. Sales at Israel Electric Corporation, which was ranked third, rose 12.2% to $3.6b., while Israel Chemicals Ltd., which secured the fourth place generated revenues of $2.98b. an increase of 10%. Israel Aircraft Industries rounded out the top five with sales of $2.34b., representing a rise of 13.9% over 2004 levels. Iscar Ltd., the metal cutting tools manufacturer, which is being bought by American investor Warren Buffett for $4b., was ranked as the country's 11th largest industrial company with a sales volume of $1b. In 2005, the total sales volume of the country's industrial companies rose by NIS 35b. or 16% to NIS 257b., according to D&B's company rating of the 150 largest industrial companies. Operating revenues of the 150 largest trade and services companies rose by 20%, or NIS 34b., to NIS 207b. compared with a year earlier. The ranking of the largest trade and service companies was also led by energy and petrol companies with Alon Israel keeping the top position with $4.27b. in operating revenues, while Delek Petroleum jumped from fourth place to second with $3.3b., followed by Zim in third place with $2.88b. Bezeq dropped to fourth place from third a year earlier, while Paz Oil occupied the fifth place on the ranking up from seventh the year before. According to Dun's 100, last year was the best for the hi-tech industry, which saw an increase of 20% in revenues counted by the leading technology companies rated by D&B compared with the ranking in 2000 - the last record year. The sales volume of high-tech companies, which make up about 40% of all industrial companies in the ranking, totaled $20b. in 2005.


Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS

Israel Weather
  • 9 - 17
    Beer Sheva
    12 - 16
    Tel Aviv - Yafo
  • 6 - 12
    Jerusalem
    9 - 14
    Haifa
  • 11 - 22
    Elat
    12 - 16
    Tiberias